An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 11/15/2024 10:23 PM
Question 20120094
Inquiry Details
References:
#1: 2022 SEER Manual
#2: ICD-O-3.2
Question:
Reportability: Given that per the 2012 SEER Manual and SINQ 20120081 VIN II-III is no longer reportable, does this change exclusively apply to VIN II-III or does it also apply to AIN II-III, VAIN II-III, etc.? See Discussion.
Discussion:
VIN II-III was a reportable condition in the past. There was a SINQ note to that effect which is now gone from the system. Would it be better to reactivate that note and put a date reference in it so that there is documentation available to confirm this disease (and other IN II-III diseases) was previously reportable? If the note is not reactivated, could there be some indication in SINQ 20120081 of the prior reportability of this disease process?
Answer:
For cases diagnosed 2021 or later, VIN II-III is reportable. Similarly, AIN II-III, VAIN II-III, etc. are reportable. For cases diagnosed 2021 or later, the primary resource for reportability is ICD-O-3.2. Squamous intraepithelial neoplasia, grade II is listed in ICD-O-3.2 as 8077/2 making it reportable. This applies to the various sites of intraepithelial neoplasia grade II including anus, vulva, and vagina.
History:
For cases diagnosed 2021 - 2020
Instructions in the 2012 SEER manual take effect for cases diagnosed January 1, 2012 and later. As of 2012, VIN II-III is not reportable. Similarly, AIN II-III, VAIN II-III, etc. are no longer reportable.
